Repare Therapeutics
(NASDAQ) RPTX
Repare Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$11.87M
Net Income (TTM)
$72.20M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RPTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Repare Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
129
CEO
Steve Forte, CPA
Website
www.reparerx.comHeadquarters
Montreal, QC H4S 2A1, CA
RPTX Financials
Key Financial Metrics (TTM)
Gross Margin
23%
Operating Margin
-6%
Net Income Margin
-6%
Return on Equity
-58%
Return on Capital
-65%
Return on Assets
-57%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$40.10M
Operating Income
$93.52M
EBITDA
$90.22M
Operating Cash Flow
$76.44M
Capital Expenditure
$0.00
Free Cash Flow
$76.44M
Cash & ST Invst.
$152.79M
Total Debt
$1.93M
Repare Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.62M
N/A
Gross Profit
$4.12M
+961.5%
Gross Margin
35.44%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
129
N/A
Net Income
$3.26M
+109.5%
EBITDA
$358.00K
+98.9%
Quarterly Fundamentals
Net Cash
$112.26M
-36.5%
Accounts Receivable
$6.49M
+99.4%
Inventory
$0.00
+100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$342.00K
-84.6%
Return on Assets
-56.96%
N/A
Return on Invested Capital
-65.23%
N/A
Free Cash Flow
$2.65M
+108.7%
Operating Cash Flow
$2.65M
+108.7%